|
GPR137C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63036251166204E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.63424829224823E-12 |
| Normal-vs-Stage2 |
6.390400E-04 |
| Normal-vs-Stage3 |
1.172790E-04 |
| Normal-vs-Stage4 |
1.242280E-03 |
| Stage1-vs-Stage2 |
2.352200E-01 |
| Stage1-vs-Stage3 |
7.358000E-02 |
| Stage1-vs-Stage4 |
6.167400E-01 |
| Stage2-vs-Stage3 |
8.743000E-01 |
| Stage2-vs-Stage4 |
6.053000E-01 |
| Stage3-vs-Stage4 |
4.712200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.66044955562938E-12 |
| Normal-vs-AfricanAmerican |
2.804000E-02 |
| Normal-vs-Asian |
4.02809999999754E-05 |
| Caucasian-vs-AfricanAmerican |
4.275400E-01 |
| Caucasian-vs-Asian |
7.658200E-01 |
| AfricanAmerican-vs-Asian |
5.401400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.83390036068954E-10 |
| Normal-vs-Female |
1.13264952972258E-12 |
| Male-vs-Female |
4.462000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.02140518265514E-14 |
| Normal-vs-Age(41-60Yrs) |
4.09280000002177E-07 |
| Normal-vs-Age(61-80Yrs) |
4.551400E-04 |
| Normal-vs-Age(81-100Yrs) |
1.606770E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.842000E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.339600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.347000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.772400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.687600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.048400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.15620000000905E-05 |
| Classical-VS-Follicular |
1.536860E-03 |
| Classical-VS-Other |
9.247400E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
4.239400E-01 |
| Tall-VS-Other |
2.028000E-01 |
| Tall-VS-Normal |
1.989650E-02 |
| Follicular-VS-Other |
2.336400E-01 |
| Follicular-VS-Normal |
9.642100E-04 |
| Other-VS-Normal |
6.675800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.85210002889846E-09 |
| Normal-vs-N1 |
6.829300E-04 |
| N0-vs-N1 |
3.813000E-01 |
|
|
